home / stock / mrtx / mrtx news


MRTX News and Press, Mirati Therapeutics Inc. From 06/07/22

Stock Information

Company Name: Mirati Therapeutics Inc.
Stock Symbol: MRTX
Market: NASDAQ
Website: mirati.com

Menu

MRTX MRTX Quote MRTX Short MRTX News MRTX Articles MRTX Message Board
Get MRTX Alerts

News, Short Squeeze, Breakout and More Instantly...

MRTX - Mirati, CymaBay top healthcare gainers; Verastem, Delcath lead losers' pack

Gainers: Mirati Therapeutics (MRTX) +23%. CymaBay Therapeutics (CBAY) +16%. Veru (VERU) +9%. Kodiak Sciences (KOD) +8%. Allarity Therapeutics (ALLR) +7%. Losers: Verastem (VSTM) -12%. Delcath Systems (DCTH) -11%. Vicarious Surgical (RBOT) -8%. CEL-...

MRTX - MCRB, MRTX and CNTX among pre market gainers

Seres Therapeutics (MCRB) +11% announces confirmatory results from investigational microbiome therapeutic SER-109 ECOSPOR IV open-label study in recurrent C. difficile infection. Kohl's KSS +10% after entering exclusive talks for $60/share sale to Franchise Group. GitLab GTLB&#...

MRTX - New Late-Breaking Data on Investigational Adagrasib Show Regression of Central Nervous System (CNS) Metastases in Patients with KRASG12C-mutated Non-Small Cell Lung Cancer (NSCLC) with Active, Untreated CNS Metastases

New Late-Breaking Data on Investigational Adagrasib Show Regression of Central Nervous System (CNS) Metastases in Patients with KRASG12C-mutated Non-Small Cell Lung Cancer (NSCLC) with Active, Untreated CNS Metastases PR Newswire Presentation marks first clinical datas...

MRTX - Blueprint Medicines, Mirati, Immunogen gain following Turning Point sale to Bristol Myers (update)

Update 12:15pm: Updates shares, adds other potential names benefitting from the deal. Blueprint Medicines (NASDAQ:BPMC) rose 4% after Bristol Myers (BMY) agreed to acquire Turning Point Therapeutics (TPTX) for over $4B in cash. Stifel said in a note that buy-rated Blueprint (BPMC) c...

MRTX - Catalyst watch: GameStop earnings, box office buzz, eyes on Amazon split

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

MRTX - AVDL, SIGA, PSHG and IOVA among mid-day movers

Gainers: Avadel Pharmaceuticals (AVDL) +123%. SIGA Technologies (SIGA) +40%. Concert Pharmaceuticals (CNCE) +30%. Farfetch (FTCH) +25%. Allarity Therapeutics (ALLR) +25%. Merus N.V. (MRUS) +23%. Tenon Medical (TNON) +22%. Arcturus Therapeutics Holdings (ARCT) +19%. Red Rob...

MRTX - Avadel, PMV Pharmaceuticals top healthcare gainers; Iovance, SpringWorks lead losers' pack

Gainers: Avadel Pharmaceuticals AVDL +61%. PMV Pharmaceuticals PMVP +25%. Alpha Tau Medical (DRTS) +18%. SIGA Technologies SIGA +18%. Allarity Therapeutics (ALLR) +17%. Losers: Iovance Biotherapeutics (IOVA) -54%. SpringWorks Therapeutics SWTX...

MRTX - Mirati extends losses after KRAS inhibitor data; Stifel says selloff is overdone

Mirati Therapeutics (NASDAQ:MRTX) continued to trade lower in the pre-market after the clinical-stage oncology company updated data for its KRAS inhibitor, adagrasib, while Stifel defended the stock noting that the post-market selloff was “overdone.” The data were generated from...

MRTX - Mirati crashes after updating mid-stage data for KRAS inhibitor in lung cancer

Mirati Therapeutics (NASDAQ:MRTX) plunged 23% in the post-market Thursday after the clinical-stage oncology company shared trial data for its oral KRAS inhibitor, adagrasib, in lung cancer patients with KRASG12C mutation . The data were derived from the registration-enabling Phase 2...

MRTX - MRTX, ACET and PMVP are among after hour movers

Gainers: Adicet  (ACET) +25%. PMV Pharmaceuticals (PMVP) +20%. Red Robin Gourmet Burgers (RRGB) +18%. Aesthetic Medical International Holdings Group  (AIH) +13%. Elevation Oncology (ELEV) +9%. Losers: Iovance Biotherapeutics (IOVA) -50%. Aurora Cannabis  (ACB) -18%. M...

Previous 10 Next 10